Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Antiretroviral pre-exposure prophylaxis reduces sexual transmission of HIV. We assessed
whether daily oral use of tenofovir disoproxil fumarate (tenofovir), an antiretroviral,
can reduce HIV transmission in injecting drug users.